| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0009 |